Palisade Bio Files Definitive Proxy Statement

TL;DR

PALISADE BIO (PBLD) proxy statement filed. Vote on company matters.

AI Summary

Palisade Bio, Inc. filed its definitive proxy statement on August 18, 2025, for its annual meeting. The company, formerly known as Seneca Biopharma, Inc. and Neuralstem, Inc., is seeking shareholder approval for various corporate matters. The filing does not disclose specific financial figures or executive compensation details in this excerpt.

Why It Matters

This filing is crucial for shareholders as it outlines the proposals they will vote on at the upcoming annual meeting, impacting the company's governance and future direction.

Risk Assessment

Risk Level: low — This is a routine proxy filing and does not contain new financial information or significant corporate events that would immediately impact stock price.

Key Players & Entities

• PALISADE BIO, INC. (company) — Registrant
• Seneca Biopharma, Inc. (company) — Former company name
• Neuralstem, Inc. (company) — Former company name
• 0001357459 (company) — Central Index Key
• 20250818 (date) — Filing date

FAQ

Key Financial Figures

• $27,000 — ments, which are not expected to exceed $27,000 in total. What does it mean if I rece
• $0.9047 — rrant that was exercised was reduced to $0.9047 per share. In exchange for exercising t
• $7,815,000 — d realize an aggregate of approximately $7,815,000 in gross proceeds if the New Warrant wa

Filing Documents

• formdef14a.htm (DEF 14A) — 139KB
• formdef14a_001.jpg (GRAPHIC) — 9KB
• proxy_001.jpg (GRAPHIC) — 524KB
• proxy_002.jpg (GRAPHIC) — 240KB
• 0001641172-25-024628.txt ( ) — 1205KB

From the Filing

DEF 14A 1 formdef14a.htm DEF 14A UNITED SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy (Amendment No.__) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material under § 240.14a-12 PALISADE BIO, INC. (Name of Registrant as Specified in its Charter) (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) Payment of Filing Fee (Check all boxes that apply): No fee required Fee paid previously with preliminary materials Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 PALISADE BIO, INC. 1902 Wright Place, Suite 200 Carlsbad, California 92008 NOTICE OF SPECIAL MEETING OF STOCKHOLDERS To Be Held on September 18, 2025 Dear Stockholder: You are invited to attend a virtual Special Meeting of Stockholders, or the “Special Meeting”, of Palisade Bio, Inc., a Delaware corporation, or the “Company,” to be held on Thursday, September 18, 2025 at 9:00 a.m. Pacific Time. The Special Meeting will be held in a virtual meeting format only, via live webcast on the Internet, with no physical in-person meeting. You will be able to attend and participate in the Special Meeting online by visiting www.proxydocs.com/PALI , where you will be able to listen to the meeting live, submit questions and vote. You will need to have the control number included in your proxy materials to join the Special Meeting. As always, we encourage you to vote your shares prior to the Special Meeting. You are being asked to vote on the following matters: 1. To approve, pursuant to Nasdaq Listing Rule 5635(d), the issuance of up to 8,637,810 shares of our common stock underlying certain warrants issued by us pursuant to the terms of that certain warrant inducement agreement dated as of July 23, 2025 (the “Warrant Inducement”) which is equal to or in excess of 20% of our common stock outstanding prior to the issuance of such warrants. We refer to this proposal as the “Warrant Exercise Proposal” or “Proposal 1.” 2. To approve the adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the foregoing proposal. We refer to this as the “Adjournment Proposal” or “Proposal 2.” A printed copy of the proxy statement for the Special Meeting (the “Proxy Statement”) is being mailed to stockholders of record who are entitled to vote at the Special Meeting on or about August 18, 2025. The Proxy Statement contains instructions on how to access the Proxy Statement through the internet, and also provides instructions on how to vote online, by telephone or by mail and includes instructions on how to receive a paper copy of proxy materials by mail. The proxy materials can be accessed directly at the following internet address: www.proxydocs.com/PALI . The foregoing items of business are more fully described in the Proxy Statement. A list of stockholders entitled to vote at the Special Meeting will be available for inspection at the Company’s corporate headquarters at the address listed above for the ten-day period prior to the Special Meeting. Only stockholders of record at the close of business on July 28, 2025 (the “Record Date”) are entitled to notice of and to vote at the Special Meeting as set forth in the Proxy Statement. You will not be able to attend the Special Meeting in person. By Order of the Board of Directors /s/ Don Williams Don Williams Chairman August 18, 2025 You are cordially invited to attend the Special Meeting. Whether or not you expect to attend the Special Meeting, PLEASE VOTE YOUR SHARES. As an alternative to voting online at the Special Meeting, you may vote via the internet, by telephone or, if you receive a paper proxy card by mailing the completed proxy card. Voting instructions are provided in the instructions printed on your proxy card. Even if you have voted by proxy, you may still vote online at the Special Meeting. Please note, however, that if your shares are held of record by a broker, bank or other agent and you wish to vote at the Special Meeting, you must follow the instructions from such organization and will need to obtain a proxy issued in your name from that record holder. PALISADE BIO, INC. 1902 Wright Place, Suite 200 Carlsbad, California 92008 PROXY FOR THE SPECIAL MEETING OF STOCKHOLDERS To Be Held on September 18, 2025 QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING Why did I receive proxy materials? The Board of Directors, or the “Board,” of Palisade Bio, Inc. (sometimes referred to as the “Company,&rd

View Full Filing

View this DEF 14A filing on SEC EDGAR